Oncolytics Biotech
ONCY
#9267
Rank
โ‚ฌ84.56 M
Marketcap
0,79ย โ‚ฌ
Share price
-7.06%
Change (1 day)
-0.49%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -โ‚ฌ22.18 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.67 Million a decrease over its 2023 earnings that were of -โ‚ฌ21.45 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ22.18 Million2.36%
2024 -โ‚ฌ21.67 Million1.01%
2023 -โ‚ฌ21.45 Million23.39%
2022 -โ‚ฌ17.38 Million-1.98%
2021 -โ‚ฌ17.74 Million9.1%
2020 -โ‚ฌ16.26 Million22.64%
2019 -โ‚ฌ13.26 Million22.78%
2018 -โ‚ฌ10.8 Million4.1%
2017 -โ‚ฌ10.37 Million4.87%
2016 -โ‚ฌ9.89 Million8.75%
2015 -โ‚ฌ9.09 Million-37.06%
2014 -โ‚ฌ14.45 Million-26.2%
2013 -โ‚ฌ19.58 Million-37.39%
2012 -โ‚ฌ31.26 Million28.8%
2011 -โ‚ฌ24.27 Million46.02%
2010 -โ‚ฌ16.63 Million35.64%
2009 -โ‚ฌ12.26 Million-14.2%
2008 -โ‚ฌ14.29 Million-0.52%
2007 -โ‚ฌ14.36 Million24.6%
2006 -โ‚ฌ11.53 Million45.34%
2005 -โ‚ฌ7.93 Million-11.8%
2004 -โ‚ฌ8.99 Million115.36%
2003 -โ‚ฌ4.18 Million13.86%
2002 -โ‚ฌ3.67 Million-5.45%
2001 -โ‚ฌ3.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Aeterna Zentaris
AEZS
-โ‚ฌ4.68 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.15 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.83 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.50 B-7,223.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-โ‚ฌ24.73 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-โ‚ฌ0.66 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA